Temozolomide
Product Images NDC 59923-703

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 59923-703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Areva Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 100mg 14cap

Box packaging label for Temozolomide Capsules USP 100 mg by Areva Pharmaceuticals. The label states the capsules are for oral administration, with 14 capsules per box. It includes storage instructions, cytotoxic warnings, and distributor information from Areva Pharmaceuticals Inc., Georgetown, IN. It also includes a barcode and a coding area.*

FDA Label Image

Carton 100mg 5cap

Packaging label for TEMOZOLOMIDE Capsules USP 100 mg per capsule by Areva Pharmaceuticals. The label indicates oral administration with a quantity of 5 capsules. It includes storage instructions, cytotoxic capsule warnings, and distributor information from Areva Pharmaceuticals Inc., Georgetown, IN. The label also shows the NDC code 59923-707-05 and a barcode.*

FDA Label Image

Carton 140mg 14cap

TEMOZOLOMIDE Capsules USP 140 mg per capsule packaging label from Areva Pharmaceuticals. The label includes strength, dosage form, package quantity of 14 capsules, and warnings for pharmacists. Storage instructions and distributor address (Areva Pharmaceuticals Inc., Georgetown, IN) are also present. The label notes the drug is for oral administration and prescription use only.*

FDA Label Image

Carton 140mg 5cap

Packaging label for Temozolomide Capsules USP 140 mg by Areva Pharmaceuticals. The label indicates oral administration, contains 5 capsules per package, and carries a caution for special dispensing information. It includes storage instructions, cytoxic warnings, and distributor details for Areva Pharmaceuticals Inc., Georgetown, IN. The label is predominantly white with black text and red Areva logos.*

FDA Label Image

Carton 180mg 14cap

Packaging label for TEMOZOLOMIDE Capsules USP 180 mg by Areva Pharmaceuticals. The label indicates the capsules are for oral administration, with 14 capsules per container. It includes dosage strength, storage instructions, pharmacist dispensing warning, and distributor information, stating the product is made in Italy.*

FDA Label Image

Carton 180mg 5cap

Packaging label for TEMOZOLOMIDE Capsules USP 180 mg by Areva Pharmaceuticals. The label shows a carton for 5 capsules, indicating oral administration. It includes storage instructions, a note that each capsule contains 180 mg temozolomide, cytotoxic warnings, and directions to read accompanying information. The label also displays the NDC 59923-711-05 and an Areva Pharmaceuticals logo.*

FDA Label Image

Carton 20mg 14cap

Packaging label for Temozolomide Capsules USP 20 mg by Areva Pharmaceuticals. The label shows a 14 capsule container, with instructions for oral administration. It includes storage information, a caution about special dispensing, and cytotoxic warnings. The label also states the product is made in Italy and includes a barcode.*

FDA Label Image

Carton 20mg 5cap

Packaging label for TEMOZOLOMIDE Capsules USP 20 mg by Areva Pharmaceuticals. The label includes dosage strength of 20 mg per capsule and states the product is for oral administration. The container holds 5 capsules. Storage instructions, distributor information, and a barcode are also visible on the label.*

FDA Label Image

Carton 250mg 5cap

Packaging label for TEMOZOLOMIDE Capsules USP, 250 mg per capsule, for oral administration. The label includes the NDC number 59923-713-05 and indicates the product contains 5 capsules per container. Labeler is Areva Pharmaceuticals. Storage instructions are to keep at 25°C with permitted excursions. Additional warnings and directions for use are provided, including cytotoxic precautions. The product is made in Italy.*

FDA Label Image

Carton 5mg 14cap

Carton packaging label for TEMOZOLOMIDE Capsules USP 5 mg, distributed by Areva Pharmaceuticals. The label indicates a quantity of 14 capsules per carton, for oral administration. Dosage strength '5 mg per capsule' is clearly printed multiple times. Additional information includes storage conditions, cytotoxicity warning, and pharmacist dispensing instructions. The label also shows barcoding and the manufacturer's location in Georgetown, IN.*

FDA Label Image

Carton 5mg 5caps

Packaging label for Temozolomide Capsules USP, 5 mg per capsule, distributed by Areva Pharmaceuticals. The label includes storage temperature instructions, pharmacist dispensing information, and warnings that the capsules are cytotoxic and must be swallowed whole. The package contains 5 capsules and is marked Rx Only.*

FDA Label Image

Figure1

A Kaplan-Meier survival curve chart showing overall survival probability over time in months for an ITT population. The chart compares two groups: RT + TMZ and RT Only, depicting that the RT + TMZ group has a higher survival probability over time. The hazard ratio with 95% confidence interval and the log-rank P-value are noted on the chart.*

FDA Label Image

Structure

Chemical structure of temozolomide, showing its molecular framework with a fused triazine ring system and functional groups including amide and methyl moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.